Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease

PLoS One. 2017 May 30;12(5):e0178488. doi: 10.1371/journal.pone.0178488. eCollection 2017.

Abstract

Background: In autosomal dominant polycystic kidney disease (ADPKD), total kidney volume (TKV) is regarded as an important biomarker of disease progression and different methods are available to assess kidney volume. The purpose of this study was to identify the most efficient kidney volume computation method to be used in clinical studies evaluating the effectiveness of treatments on ADPKD progression.

Methods and findings: We measured single kidney volume (SKV) on two series of MR and CT images from clinical studies on ADPKD (experimental dataset) by two independent operators (expert and beginner), twice, using all of the available methods: polyline manual tracing (reference method), free-hand manual tracing, semi-automatic tracing, Stereology, Mid-slice and Ellipsoid method. Additionally, the expert operator also measured the kidney length. We compared different methods for reproducibility, accuracy, precision, and time required. In addition, we performed a validation study to evaluate the sensitivity of these methods to detect the between-treatment group difference in TKV change over one year, using MR images from a previous clinical study. Reproducibility was higher on CT than MR for all methods, being highest for manual and semiautomatic contouring methods (planimetry). On MR, planimetry showed highest accuracy and precision, while on CT accuracy and precision of both planimetry and Stereology methods were comparable. Mid-slice and Ellipsoid method, as well as kidney length were fast but provided only a rough estimate of kidney volume. The results of the validation study indicated that planimetry and Stereology allow using an importantly lower number of patients to detect changes in kidney volume induced by drug treatment as compared to other methods.

Conclusions: Planimetry should be preferred over fast and simplified methods for accurately monitoring ADPKD progression and assessing drug treatment effects. Expert operators, especially on MR images, are required for performing reliable estimation of kidney volume. The use of efficient TKV quantification methods considerably reduces the number of patients to enrol in clinical investigations, making them more feasible and significant.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Female
  • Humans
  • Kidney / pathology*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Polycystic Kidney, Autosomal Dominant / diagnosis*
  • Polycystic Kidney, Autosomal Dominant / pathology
  • Tomography, X-Ray Computed

Grants and funding

This study was funded in part by ERA – EDTA (EuroCYST Initiative), and by PKD Foundation, Kansas City, MO, USA (grant number 01TRN07a). KS was supported by a Marie Curie fellowship from the European Community (FP7-PEOPLE-MCA-ITN-317246, TranCYST project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.